Journal of Shanghai Jiao Tong University (Medical Science) >

2024 , Vol. 44 >Issue 12: 1536 - 1544

DOI: https://doi.org/10.3969/j.issn.1674-8115.2024.12.006

Basic research

Inhibition of Tannerpin-M encoded by periodontal pathogens on serine proteases released by granulocytes

  • Zihao PAN ,
  • Jiawei XU ,
  • Aiwu ZHOU
Expand
  • 1.Department of Biopharmaceuticals and Food Science, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China
    2.Department of Biological Engineering, Zhuhai Campus of Zunyi Medical University, Zhuhai 519040, China
    3.Department of Pathophysiology, Shanghai Jiao Tong University College of Basic Medical Sciences, Shanghai 200025, China
ZHOU Aiwu，E-mail: awz20@shsmu.edu.cn.

Received date: 2024-06-19

  Accepted date: 2024-08-06

  Online published: 2024-09-05

Fold

Abstract

Objective ·To prepare a serine protease inhibitor (Serpin) derived from Tannerella which is associated with periodontosis, and analyze its specificity in inhibiting target proteases and its structural characteristics. Methods ·Through amino acid sequence analysis, a Serpin from the human oral microbiome database (eHOMD) was selected and expressed in Escherichia coli. The recombinant protein was purified using methods such as nickel ion affinity chromatography. Its specificity in inhibiting serine proteases was analyzed, followed by an analysis of its three-dimensional spatial structure using structural biology methods. Results ·A novel Serpin, named Tannerpin-M, with methionine as the active center P1 residue, was identified, and a high-purity recombinant protein was successfully prepared from Escherichia coli BL21 (DE3). Further activity testing demonstrated that recombinant Tannerpin-M could effectively form SDS-stable covalent complexes with proteases derived from granulocytes (human neutrophil elastase, cathepsin G, and proteinase 3), as well as with other proteases including kallikrein 1 (KLK1), KLK7, and elastase. Tannerpin-M inhibited KLK7 with a second-order association rate constant of 4.12×104 L/(mol·s). The crystal structure of Tannerpin-M in its relaxed state conformation was resolved at a resolution of 2.4 ? (1 ?=0.1 nm). It revealed that Tannerpin-M possessed a significantly elongated reactive center loop and could undergo the classical conformational transition from a stressed to a relaxed state. Conclusion ·Tannerpin-M, derived from oral pathogenic bacteria, is a typical inhibitory Serpin, and can effectively inhibit the serine protease released by granulocytes, by which it may protect the oral pathogenic bacteria from attacks of the human immune system.

Key words： serine protease inhibitor; Tannerella; prokaryotic expression; crystal structure; periodontal pathogen

Cite this article

Zihao PAN , Jiawei XU , Aiwu ZHOU . Inhibition of Tannerpin-M encoded by periodontal pathogens on serine proteases released by granulocytes[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2024 , 44(12) : 1536 -1544 . DOI: 10.3969/j.issn.1674-8115.2024.12.006

References

1 LEYS E J, LYONS S R, MOESCHBERGER M L, et al. Association of Bacteroides forsythus and a novel Bacteroides phylotype with periodontitis[J]. J Clin Microbiol, 2002, 40(3): 821-825.
2 FARRELL J J, ZHANG L, ZHOU H, et al. Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer[J]. Gut, 2012, 61(4): 582-588.
3 KSIAZEK M, MIZGALSKA D, ENGHILD J J, et al. Miropin, a novel bacterial serpin from the periodontopathogen Tannerella forsythia, inhibits a broad range of proteases by using different peptide bonds within the reactive center loop[J]. J Biol Chem, 2015, 290(1): 658-670.
4 LAW R H, ZHANG Q, MCGOWAN S, et al. An overview of the serpin superfamily[J]. Genome Biol, 2006, 7(5): 216.
5 CARRELL R W, EVANS D L, STEIN P E. Mobile reactive centre of serpins and the control of thrombosis[J]. Nature, 1991, 353: 576-578.
6 GETTINS P G. Serpin structure, mechanism, and function[J]. Chem Rev, 2002, 102(12): 4751-4804.
7 HEIT C, JACKSON B C, MCANDREWS M, et al. Update of the human and mouse SERPIN gene superfamily[J]. Hum Genom, 2013, 7: 22.
8 BOUDIER C, BIETH J G. The reaction of serpins with proteinases involves important enthalpy changes[J]. Biochemistry, 2001, 40(33): 9962-9967.
9 HUNTINGTON J A, READ R J, CARRELL R W. Structure of a serpin-protease complex shows inhibition by deformation[J]. Nature, 2000, 407: 923-926.
10 IKEZOE T. Advances in the diagnosis and treatment of disseminated intravascular coagulation in haematological malignancies[J]. Int J Hematol, 2021, 113(1): 34-44.
11 YANG L, MANITHODY C, QURESHI S H, et al. Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin[J]. Thromb Haemost, 2010, 103(2): 277-283.
12 MAAS C, DE MAAT S. Therapeutic SERPINs: improving on nature[J]. Front Cardiovasc Med, 2021, 8: 648349.
13 LOMAS D A, LI-EVANS D, FINCH J T, et al. The mechanism of Z α1-antitrypsin accumulation in the liver[J]. Nature, 1992, 357: 605-607.
14 SCHECHTER I, BERGER A. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain[J]. Biochem Biophys Res Commun, 1968, 32(5): 898-902.
15 SPENCE M A, MORTIMER M D, BUCKLE A M, et al. A comprehensive phylogenetic analysis of the serpin superfamily[J]. Mol Biol Evol, 2021, 38(7): 2915-2929.
16 Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography[J]. Acta Crystallogr D Biol Crystallogr, 1994, 50(pt 5): 760-763.
17 MCCOY A J, GROSSE-KUNSTLEVE R W, ADAMS P D, et al. Phaser crystallographic software[J]. J Appl Crystallogr, 2007, 40(pt 4): 658-674.
18 MURSHUDOV G N, SKUBáK P, LEBEDEV A A, et al. REFMAC5 for the refinement of macromolecular crystal structures[J]. Acta Crystallogr D Biol Crystallogr, 2011, 67(pt 4): 355-367.
19 EMSLEY P, COWTAN K. Coot: model-building tools for molecular graphics[J]. Acta Crystallogr D Biol Crystallogr, 2004, 60(pt 12 pt 1): 2126-2132.
20 WEI H, CAI H, WU J, et al. Heparin binds lamprey angiotensinogen and promotes thrombin inhibition through a template mechanism[J]. J Biol Chem, 2016, 291(48): 24900-24911.
21 XU J, YE W, YANG T T, et al. DNA accelerates the protease inhibition of a bacterial serpin chloropin[J]. Front Mol Biosci, 2023, 10: 1157186.
22 MAGGIORA L L, SMITH C W, ZHANG Z Y. A general method for the preparation of internally quenched fluorogenic protease substrates using solid-phase peptide synthesis[J]. J Med Chem, 1992, 35(21): 3727-3730.
23 WEI Z, YAN Y, CARRELL R W, et al. Crystal structure of protein Z-dependent inhibitor complex shows how protein Z functions as a cofactor in the membrane inhibition of factor X[J]. Blood, 2009, 114(17): 3662-3667.
24 IRVING J A, CABRITA L D, ROSSJOHN J, et al. The 1.5 ? crystal structure of a prokaryote serpin: controlling conformational change in a heated environment[J]. Structure, 2003, 11(4): 387-397.
25 IVANOV D, EMONET C, FOATA F, et al. A serpin from the gut bacterium Bifidobacterium longum inhibits eukaryotic elastase-like serine proteases[J]. J Biol Chem, 2006, 281(25): 17246-17252.
26 JUMPER J, EVANS R, PRITZEL A, et al. Highly accurate protein structure prediction with AlphaFold[J]. Nature, 2021, 596: 583-589.
27 JIN L, ABRAHAMS J P, SKINNER R, et al. The anticoagulant activation of antithrombin by heparin[J]. Proc Natl Acad Sci USA, 1997, 94(26): 14683-14688.
28 MKAOUAR H, MARIAULE V, RHIMI S, et al. Gut serpinome: emerging evidence in IBD[J]. Int J Mol Sci, 2021, 22(11): 6088.
29 IRVING J A, PIKE R N, DAI W, et al. Evidence that serpin architecture intrinsically supports papain-like cysteine protease inhibition: engineering α1-antitrypsin to inhibit cathepsin proteases[J]. Biochemistry, 2002, 41(15): 4998-5004.
30 CABRITA L D, IRVING J A, PEARCE M C, et al. Aeropin from the extremophile Pyrobaculum aerophilum bypasses the serpin misfolding trap[J]. J Biol Chem, 2007, 282(37): 26802-26809.
31 TANAKA S, KOGA Y, TAKANO K, et al. Inhibition of chymotrypsin- and subtilisin-like serine proteases with Tk-serpin from hyperthermophilic archaeon Thermococcus kodakaraensis[J]. Biochim Biophys Acta, 2011, 1814(2): 299-307.
32 SANRATTANA W, MAAS C, DE MAAT S. SERPINs-from trap to treatment[J]. Front Med (Lausanne), 2019, 6: 25.
33 LAWRENCE D A, OLSON S T, MUHAMMAD S, et al. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into β-sheet A[J]. J Biol Chem, 2000, 275(8): 5839-5844.
34 OWEN M C, BRENNAN S O, LEWIS J H, et al. Mutation of antitrypsin to antithrombin: α1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder[J]. N Engl J Med, 1983, 309(12): 694-698.
35 GETTINS P G, OLSON S T. Exosite determinants of serpin specificity[J]. J Biol Chem, 2009, 284(31): 20441-20445.
Options
Outlines

/

〈 〉